Braud V M, Allan D S, Wilson D, McMichael A J
Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, OX3 9DS, UK.
Curr Biol. 1998 Jan 1;8(1):1-10. doi: 10.1016/s0960-9822(98)70014-4.
The human major histocompatibility complex (MHC) class lb molecule HLA-E is transcribed in most tissues but little is known about its localisation within the cell. We have recently shown that HLA-E binds signal-sequence-derived peptides from human MHC class I molecules in vitro.
Using a newly characterised antibody recognising HLA-E, we show that HLA-E is expressed at the cell surface. We demonstrate that HLA-E surface expression is correlated with the presence of MHC class I molecules which provide suitable leader sequence peptides capable of binding to HLA-E. Further studies on the interaction of HLA-E with molecules in the endoplasmic reticulum revealed that HLA-E associates with the transporter associated with antigen processing (TAP) and calreticulin, and that HLA-E expression is TAP-dependent and tapasin-dependent. In addition, HLA-E dissociates from TAP upon binding of MHC class I leader sequence peptides.
These experiments establish that surface expression of HLA-E is regulated by the binding of a restricted pool of peptides from the leader sequence of MHC class I molecules. The correlation between HLA-E and MHC class I surface expression might be relevant to the function of HLA-E. Our results also show that, although these HLA-E binding peptides are derived from signal sequences, they may be released back into the cytosol and subsequently translocated by the TAP complex and loaded onto HLA-E molecules.
人类主要组织相容性复合体(MHC)I类b分子HLA-E在大多数组织中都有转录,但对其在细胞内的定位了解甚少。我们最近发现,HLA-E在体外能结合源自人类MHC I类分子的信号序列肽段。
利用一种新鉴定的识别HLA-E的抗体,我们发现HLA-E在细胞表面表达。我们证明,HLA-E的表面表达与能够提供适合结合HLA-E的前导序列肽段的MHC I类分子的存在相关。对HLA-E与内质网中分子相互作用的进一步研究表明,HLA-E与抗原加工相关转运体(TAP)和钙网蛋白相关联,并且HLA-E的表达依赖于TAP和tapasin。此外,当MHC I类前导序列肽段结合后,HLA-E会从TAP上解离。
这些实验证实,HLA-E的表面表达受来自MHC I类分子前导序列的有限肽段库结合的调控。HLA-E与MHC I类分子表面表达之间的相关性可能与HLA-E的功能有关。我们的结果还表明,尽管这些HLA-E结合肽段源自信号序列,但它们可能会释放回细胞质中,随后被TAP复合体转运并加载到HLA-E分子上。